The incidence, duration, and risk factors for diagnostic delays associated with blastomycosis
Medical Mycology · 2026
DOI: 10.1093/mmy/myag009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Mycology, 2026. Verfasst von Desmond D Barber und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Iowa, Iowa City, IA, 52242, USA. Hauptthemen laut MEDLINE: Blastomycosis, Delayed Diagnosis. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AHRQ HHS, Agency for Healthcare Research and Quality.
Abstract (Originalsprache)
Blastomycosis is a rare, fungal infection often with symptoms resembling bacterial or viral pneumonia, and sometimes lung cancer. Delay in diagnosing blastomycosis is associated with worse clinical outcomes, but factors contributing to diagnostic delays remain poorly understood. This study aims to estimate the incidence and duration of diagnostic delays for blastomycosis and identify risk factors associated with missed diagnostic opportunities. We conducted a retrospective cohort study using longitudinal insurance claims data from the Merative MarketScan Research Databases (2001–2022). Patients with blastomycosis were identified using ICD-9/10 codes, and diagnostic delays were estimated using a case-crossover analysis. We estimated the number of potential missed diagnostic opportunities (i.e., healthcare visits prior to the blastomycosis diagnosis with symptoms suggestive of the disease) and identified potential risk factors for delays. A total of 3825 patients with blastomycosis were identified. Of these, 41% experienced at least one missed diagnostic opportunity, with an average of 3.2 missed visits before diagnosis. The average diagnostic delay was 26.82 days (95% confidence interval: 24.57–28.96), with 17% of patients having delays lasting over a month. Missed opportunities occurred primarily in outpatient settings (59.4%). Risk factors for delayed diagnosis included history of diabetes, prior pulmonary conditions (e.g., chronic obstructive pulmonary disease), and respiratory therapies (e.g., antibiotics, inhalers). Diagnostic delays for blastomycosis are common. The association of delays with pre-existing pulmonary conditions underscore the need for heightened clinical suspicion in patients with respiratory symptoms. Education about risk factors for missed opportunities may be helpful in improving timely diagnosis and hopefully will impact patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Iowa, Iowa City, IA, 52242, USA.
- Department of Biostatistics, University of Iowa, Iowa City, IA, 52242, USA.
- Department of Internal Medicine, University of California, Davis, Davis, CA, 95616, USA.
- Department of Internal Medicine, Johns Hopkins University, Baltimore, MD, 21218, USA.
ORCID-Profile: Aaron C Miller, Philip M Polgreen
Förderung
- AHRQ HHS
- Agency for Healthcare Research and Quality
Zitieren
APA
Barber, D. D., Struble, R. D., Arakkal, A. T., Thompson, G. R., Baddley, J. W., Cavanaugh, J. E., Miller, A. C., & Polgreen, P. M. (2026). The incidence, duration, and risk factors for diagnostic delays associated with blastomycosis. Medical Mycology. https://doi.org/10.1093/mmy/myag009
Vancouver
Barber DD, Struble RD, Arakkal AT, Thompson GR, Baddley JW, Cavanaugh JE, et al. The incidence, duration, and risk factors for diagnostic delays associated with blastomycosis. Medical Mycology. 2026. doi:10.1093/mmy/myag009
BibTeX
@article{Barber2026,
author = {Barber, Desmond D and Struble, Roger D and Arakkal, Alan T and Thompson, George R and Baddley, John W and Cavanaugh, Joseph E and Miller, Aaron C and Polgreen, Philip M},
title = {The incidence, duration, and risk factors for diagnostic delays associated with blastomycosis},
journal = {Medical Mycology},
year = {2026},
doi = {10.1093/mmy/myag009}
}
EUVIMED